A composition formulated for dose-wise delivery to a breathing passageway of a human the composition comprising a carrier solution containing (+)naloxone and a pharmacologically effective amount of at least one adrenergic agonist the (+)naloxone and agonist forming a mixture in the carrier. The at least one adrenergic agonist is selected from the group consisting of epinephrine isoproterenol abluterol aminophyline beclomethasone dyphylline flunisolide isoetharine metaproterenol oxtriphylline ter...

A composition formulated for dose-wise delivery to a breathing passageway of a human the composition comprising a carrier solution containing (+)naloxone and a pharmacologically effective amount of at least one adrenergic agonist the (+)naloxone and agonist forming a mixture in the carrier. The at least o ne adrenergic agonist is selected from the group consisting of epinephrine isoproterenol abluterol aminophyline beclomethasone dyphylline flunisolide isoetharine metaproterenol oxtriphylline ...

A composition formulated for dose-wise delivery to a breathing passageway of a human the composition comprising a carrier solution containing (+)naloxone and a pharmacologically effective amount of at least one adrenergic agonist the (+)naloxone and agonist forming a mixture in the carrier. The at least one adrenergic agonist is selected from the group consisting of epinephrine isoproterenol abluterol aminophyline beclomethasone dyphylline flunisolide isoetharine metaproterenol oxtriphylline ter...

A composition formulated for dose-wise delivery to a breathing passageway of a human the composition comprising a carrier solution containing (+)naloxone and a pharmacologically effective amount of at least one adrenergic agonist the (+)naloxone and agonist forming a mixture in the carrier. The at least one adrenergic agonist is selected from the group consisting of epinephrine isoproterenol albuterol aminophylline beclomethasone dyphylline flunisolide isoetharine metaproterenol oxtriphylline te...